Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Theodore Phillips

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of Managed Care Pharmacy : JMCP|April 4, 2012
Consensus statements from a panel of U.S. managed care pharmacists and physicians for management of multiple sclerosis agentsJ Theodore Phillips
Archives of Neurology|February 14, 2007
What causes multiple sclerosis to worsen?J Theodore Phillips
Archives of Neurology|April 14, 2010
Interferon neutralizing antibodies in multiple sclerosis: a new perspectiveJ Theodore Phillips
Therapeutic Advances in Neurological Disorders|December 25, 2010
Natalizumab: benefit outweighs risk in selected patients with multiple sclerosisJ Theodore Phillips, Elliot M Frohman
Seminars in Neurology|May 28, 2013
BG-12 in multiple sclerosisJ Theodore Phillips, Robert J Fox
International Journal of MS Care|July 2, 2020
Dimethyl Fumarate: A Review of Efficacy and Practical Management Strategies for Common Adverse Events in Patients with Multiple SclerosisJ Theodore Phillips, Stephanie Agrella, Robert J Fox
Immunology Today|October 8, 2014
Primordial MHC function may be best served by monomorphismJ Wayne Streilein, A Gerboth-Darden, J Theodore Phillips
Multiple Sclerosis and Related Disorders|April 17, 2015
Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: Experiences of an international panelJ Theodore Phillips, Michael Hutchinson, Robert Fox, et al.
Neurology. Clinical Practice|August 31, 2016
Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: Evolution of treatment practicesCarlo Tornatore, J Theodore Phillips, Omar Khan, et al.
BMC Neurology|October 18, 2011
An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjectsJ Theodore Phillips, Edward Fox, William Grainger, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of Managed Care Pharmacy : JMCP|April 4, 2012
Consensus statements from a panel of U.S. managed care pharmacists and physicians for management of multiple sclerosis agentsJ Theodore Phillips
Archives of Neurology|February 14, 2007
What causes multiple sclerosis to worsen?J Theodore Phillips
Archives of Neurology|April 14, 2010
Interferon neutralizing antibodies in multiple sclerosis: a new perspectiveJ Theodore Phillips
Therapeutic Advances in Neurological Disorders|December 25, 2010
Natalizumab: benefit outweighs risk in selected patients with multiple sclerosisJ Theodore Phillips, Elliot M Frohman
Seminars in Neurology|May 28, 2013
BG-12 in multiple sclerosisJ Theodore Phillips, Robert J Fox
International Journal of MS Care|July 2, 2020
Dimethyl Fumarate: A Review of Efficacy and Practical Management Strategies for Common Adverse Events in Patients with Multiple SclerosisJ Theodore Phillips, Stephanie Agrella, Robert J Fox
Immunology Today|October 8, 2014
Primordial MHC function may be best served by monomorphismJ Wayne Streilein, A Gerboth-Darden, J Theodore Phillips
Multiple Sclerosis and Related Disorders|April 17, 2015
Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: Experiences of an international panelJ Theodore Phillips, Michael Hutchinson, Robert Fox, et al.
Neurology. Clinical Practice|August 31, 2016
Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: Evolution of treatment practicesCarlo Tornatore, J Theodore Phillips, Omar Khan, et al.
BMC Neurology|October 18, 2011
An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjectsJ Theodore Phillips, Edward Fox, William Grainger, et al.
Pageof 5